Literature DB >> 16715202

Opsoclonus-myoclonus syndrome in an adult with malignant melanoma.

K-Y Jung, J Youn, C-S Chung.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16715202     DOI： 10.1007/s00415-006-0026-1

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Paraneoplastic opsoclonus-myoclonus secondary to malignant melanoma.

Authors:  J R Berger; E Mehari
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage.

Authors:  J H Rees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

3.  Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus.

Authors:  L Bataller; F Graus; A Saiz; J J Vilchez
Journal:  Brain       Date:  2001-02       Impact factor: 13.501

4.  Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome.

Authors:  N E Anderson; C Budde-Steffen; M K Rosenblum; F Graus; D Ford; B J Synek; J B Posner
Journal:  Medicine (Baltimore)       Date:  1988-03       Impact factor: 1.889

Review 5.  Advances in paraneoplastic neurological syndromes.

Authors:  Jérôme Honnorat; Stéphanie Cartalat-Carel
Journal:  Curr Opin Oncol       Date:  2004-11       Impact factor: 3.645

6.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154
  6 in total
  6 in total

Review 1.  Paraneoplastic movement disorders.

Authors:  Shyamal H Mehta; John C Morgan; Kapil D Sethi
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

2.  New-Onset Refractory Status Epilepticus (NORSE) as a Recurrence of Anti-Neuronal Nuclear Antibody 2 (ANNA-2) Encephalitis After Immune Checkpoint Inhibition Therapy.

Authors:  Danielle Pitter; Luis Mejico; Julius G Latorre; Carolina Cuello-Oderiz
Journal:  Cureus       Date:  2021-06-30

3.  Adult-onset opsoclonus-myoclonus-ataxia syndrome as a manifestation of brazilian lyme disease-like syndrome: a case report and review of literature.

Authors:  Angelina Maria Martins Lino; Raphael Ribeiro Spera; Fernando Peixoto Ferraz de Campos; Christian Henrique de Andrade Freitas; Márcio Ricardo Taveira Garcia; Leonardo da Costa Lopes; Aleksander Snioka Prokopowitsch
Journal:  Autops Case Rep       Date:  2014-03-31

4.  Opsoclonus-myoclonus syndrome with severe clinical course and beneficial outcome: A case report.

Authors:  Ewa Koziorowska-Gawron; Magdalena Koszewicz; Joanna Bladowska; Maria Ejma; Slawomir Budrewicz
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

Review 5.  Update on opsoclonus-myoclonus syndrome in adults.

Authors:  Sun-Young Oh; Ji-Soo Kim; Marianne Dieterich
Journal:  J Neurol       Date:  2018-11-27       Impact factor: 4.849

6.  Paraneoplastic opsoclonus-myoclonus syndrome secondary to melanoma metastasis form occult primary cancer.

Authors:  Jaime D Mondragón; Omar Jiménez-Zarazúa; Lourdes N Vélez-Ramírez; María Andrea Martínez-Rivera; Samnir Enríquez-Maciel; Jesús González-Guzmán; Martha Mercedes Alvarez-Delgado; Pedro Luis González-Carrillo
Journal:  Case Rep Neurol       Date:  2019-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.